GoldenGolden
Sofinnova Partners

Sofinnova Partners

An independent venture capital firm based in Paris that provides funding for seed, early stage and late stage biotechnology ventures

Sofinnova Partners is an independent venture capital firm from Paris, France that provides funding for seed, early stage and late stage ventures. Founded in 1972, the firm has financed and has partnered with almost 500 companies. They invest in companies in the life science sector, especially those that work with biopharmaceuticals, biotech, medical devices, and industrial biotechnology. It usually invests in Round A, and leads its portfolio companies until exit.

The company prioritizes projects with strong intellectual property and whose founders have pharmaceutical or industrial experience. They invest in start-ups usually from the academic world, as well as spin-offs.

Timeline

July 30, 1972
Founded

Funded Companies

Company
Description
Industry
Website
Location
Synthace

Synthace is a software company based out of London, UK building automation software that gives biologists the ability to control and analyze the performance of lab hardware.

A chemical company that uses biotechnology and chemical catalysis to transform renewable feedstock into chemicals.

DNA Script is a DNA synthesis company founded by Thomas Ybert, Sylvain Gariel, and Xavier Gordon in 2014, and headquartered in Paris, France.

Tesaro is a biopharmaceutical company focused on identifying cancer therapies, acquired by GSK in 2019.

A biotechnology company using microbiology and chemistry to produce consumer goods and industrial products.

MISSION Therapeutics is a Cambridge, Cambridgeshire-based biotechnology company offering a platform for the development of small molecule drugs that selectively target deubiquitylating enzymes.

Avantium Technologies is an Amsterdam-based manufacturing company offering research and development for products and applications in the energy, chemicals, and pharmaceuticals industry.

Delinia is a biotechnology company that is developing novel therapeutics for treating autoimmune diseases.

Biosyntia is a Danish start-up company focused on synthetic biology.

A biopharmaceutical company discovering and developing small molecules that target G protein-coupled receptors

GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.

ASSIA is a Redwood Shores, California-based company founded in 2003 by Assia Cioffi.

Odoo is an open-source business management software platform including CRM, e-commerce and procurement management services.

MetGen is a Kaarina-based chemical and enzyme company.

Amplyx Pharmaceuticals, Inc. is a preclinical stage company focusing on the development of small molecule drugs.

Aledia is a company founded by Giorgio Anania, Philippe Gilet and Xavier Hugon.

ProQR Therapeutics is a biotechnology company that is committed to changing lives.

ReVolt Technology is a company that emerged from SINTEF, Norway.

A biotechnology company developing immuno-oncology therapies and therapeutic vaccines

Agrosavfe is a Belgium-based company founded in 2013.

RefleXion Medical is a Hayward, California-based developer of medical diagnostics and related tools.

Laszlo Systems is a company founded by David Temkin.

Oxxius SA is a Lannion-based company founded by Thierry Georges.

72 Results
Results per page:
Page 1 of 3

Associated investment funds

Investment Fund
Total offering (USD)
Total sold (USD)
Location
Date signed
4 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Lucia Faccio

Partner, Sofinnova Telethon Fund

Anne Osdoit

Partner

Denis Lucquin

Managing Partner

Dominique Verdier

Operations

Guillaume Baxter

Senior Associate

Jacques Theurillat

Partner, Crossover fund

Lamia Idrissi

Operations

Lukas Guenther

Venture Partner

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Abivax

AblaCare

AFYX Therapeutics

AgroSavfe

Comet Biorefining

Comet Therapeutics

DMC Biotechnologies

Inotrem

Microphyt

TISSIUM

News

Title
Author
Date
Publisher
Description
Ben Adams
March 3, 2021
FierceBiotech
Sofinnova Partners has pulled in a healthy €445 million ($540 million) in its latest capital raise as the European venture capital firm seeks out late-stage plays in biotech and medtech.
Dan Taylor
March 3, 2021
Tech.eu
Paris, London and Milan-based Sofinnova Partners has recently announced the closing of their oversubscribed late-stage healthcare crossover fund at €445 Million. This now comprises the largest crossover investor dedicated late-stage biopharma and medtech fund in Europe. Sofinnova is expected to Maintain their focus on European companies in need of scale-up capital, but will also support [...]
Freya Pratty
March 3, 2021
Sifted
Sofinnova Partners, a Paris and London-based VC firm, has closed a new €445m fund for late-stage healthtech investments in Europe.
Amirah Al Idrus
January 28, 2021
FierceBiotech
Roche's venture arm is joining the likes of Sofinnova Partners and AbbVie in backing Italy's Enthera Pharmaceuticals, bringing the diabetes-focused biotech's series A round to €35 million ($42 million). The funding will bankroll the company's lead program, Ent001, to clinical proof of concept.
Melia Russell
November 24, 2020
Business Insider
All year, Business Insider published lists of rising startups, which featured over 350 companies. We went back and chose our top 100 from that crop.
FinSMEs
November 23, 2020
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.